EBS
EBS
NYSE · Biotechnology

Emergent Biosolutions Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.00
-0.14 (-1.72%)
As of Jun 21, 10:19 PM ET ·
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +238.5% upside
Low Target $18.81
Average Target $27.08
High Target $37.55
Current Price $8.00
Current
$8.00
Target
$27.08
$18.81 $27.08 avg $37.55
Scenario Analysis
Bear Case
$18.81
135.1%
Low target
Base Case
$27.08
+238.5%
Avg target
Bull Case
$37.55
+369.4%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$14.06
-43.1% from high
52-Week Low
$5.62
+42.3% from low
Target vs 52W High
$27.08
+92.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%